Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Position Increased by Fifth Third Wealth Advisors LLC
Fifth Third Wealth Advisors LLC raised its holdings in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) by 96.3% in the third quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 997 shares of the pharmaceutical company’s stock after buying an additional 489 shares during the period. […]
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Shares Bought by Portfolio Design Labs LLC
Portfolio Design Labs LLC lifted its holdings in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) by 123.0% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 4,579 shares of the pharmaceutical company’s stock after buying an additional 2,526 shares during […]
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Shares Bought by EagleClaw Capital Managment LLC
EagleClaw Capital Managment LLC increased its stake in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) by 2.7% in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 7,625 shares of the pharmaceutical company’s stock after purchasing an additional 200 shares during the quarter. EagleClaw […]
Knuff & Co LLC Sells 150 Shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)
Knuff & Co LLC reduced its stake in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) by 1.0% during the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 14,193 shares of the pharmaceutical company’s stock after selling 150 shares during the quarter. […]
Princeton Capital Management LLC Acquires 74 Shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)
Princeton Capital Management LLC increased its holdings in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) by 0.5% in the third quarter, according to its most recent filing with the SEC. The fund owned 15,110 shares of the pharmaceutical company’s stock after acquiring an additional 74 shares during the period. Vertex Pharmaceuticals comprises 2.2% […]
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Shares Bought by Banque Cantonale Vaudoise
Banque Cantonale Vaudoise boosted its position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) by 354.2% in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 11,182 shares of the pharmaceutical company’s stock after purchasing an additional 8,720 shares during the period. Banque Cantonale Vaudoise’s […]
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Shares Acquired by Adero Partners LLC
Adero Partners LLC grew its stake in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) by 2.2% in the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 1,342 shares of the pharmaceutical company’s stock after buying an additional 29 shares during the quarter. Adero […]
Swiss National Bank Acquires 1,200 Shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)
Swiss National Bank grew its holdings in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) by 0.2% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 766,000 shares of the pharmaceutical company’s stock after acquiring an additional 1,200 shares during […]
Kentucky Retirement Systems Trims Position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)
Kentucky Retirement Systems lowered its stake in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) by 7.5% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 17,981 shares of the pharmaceutical company’s stock after selling 1,465 shares during the quarter. Kentucky Retirement Systems’ […]
last updated on 21 Nov 13:18